Mode
Text Size
Log in / Sign up
N/A N=146 Randomized Prevention

Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects

Risk-Taking · Adolescent Behavior

Enrolled (actual)
146
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Changes in Emotional Regulation — 54.43; 52.02; 54.47; 60.77 T Score — p=0.003

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Pathways for African-Americans' Success (PAAS) (Behavioral)
Age
Pediatric · 11+ yrs
Sex
All
Sponsor
University of California, Irvine
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Changes in Emotional Regulation
54.43; 52.02; 54.47; 60.77 0.003 sig
SECONDARY
Changes in Cognitive Regulation
55.41; 54.51; 51.81; 55.66 0.45

Summary

Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, including HIV/AIDS and violence, leading to premature death. The investigators previously showed that an intervention program reduces HIV-risk vulnerability behaviors in many African-American youth. The investigators aim to measure how the program affects different regions of the brain in order to better prevent or reduce such risky behaviors among African-American youth.

Eligibility Criteria

Inclusion Criteria

  • Subject is of African-American racial status (self-reported)
  • Subject can speak and read English
  • Subject and parent/legal guardian agree to participate in the 6-week PAAS program
  • Subject and parent/legal guardian agree to complete all assessments
  • Subject must meet MRI safety eligibility

Exclusion Criteria

  • Subject has a major medical problem (e.g. neurological disorders)
  • Subject is on medication(s) that affects the central nervous system
  • Subject has behavioral/emotional problems at a clinical level (parent and/or youth report)
  • Subject is pregnant or suspected of being pregnant (based on pregnancy test)
  • Subject is color-blind
  • Subject has claustrophobia
  • Subject has metallic implants
  • Subject drinks alcohol in the week prior to entry into the study (based on urine drug screen)
  • Subject uses drugs in the week prior to entry into the study (based on urine drug screen)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03370393). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search